Wang et al. confirmed the over-expression of PD-L1 though immunohistochemistry in a cohort of 28 somatotropinomas, suggesting that the PD-L1 blockage can be a possible treatment for acromegaly patients [55]. The gene discussed is CD274; the disease is growth hormone-producing pituitary gland neoplasm.